Moderate hypofractionated radiotherapy for post-operative treatment of prostate cancer: long-term outcome and pattern of toxicity.

Ciro FranzeseMarco BadalamentiDavide BaldacciniGiuseppe D'AgostinoTiziana ComitoDavide FranceschiniElena ClericiPierina NavarriaGiacomo ReggioriStefano TomatisMarta Scorsetti

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2020)

The present paper demonstrates the long-term safety and efficacy of MHRT for postoperative prostate cancer. Reduction of treatment time in long-course radiotherapy has advantages in terms of both patients' quality of life and departmental organization.

Keyphrases

prostate cancer
radiation therapy
early stage
radical prostatectomy
end stage renal disease
ejection fraction
chronic kidney disease
locally advanced
newly diagnosed
radiation induced
squamous cell carcinoma
oxidative stress
small cell lung cancer
combination therapy
patient reported outcomes
smoking cessation